Myelin Oligodendrocyte Glycoprotein Antibody Disorders (MOGAD)
Brenda Banwell, MD, FAAN, presented this session, meant for participants to “gain an understanding of the new international MOGAD diagnostic criteria and their application in clinical practice using both didactic and case examples; be able to illustrate key neuroimaging features of MOGAD; and discuss current therapies and future clinical trials for pediatric and adult MOGAD.” Dr. Banwell focused clinical features, and management, while Guilia Fadda discussed MOGAD diagnostic criteria, and Eoin Flanagan reviewed imaging features of MOGAD and differential.
Applied Neuropharmacology in Clinical Practice: Multiple Sclerosis
Robert Brown, MD, MPH, FAAN, and Calli Cook, FNP-C, FAANP, covered a spectrum of medical management strategies for multiple sclerosis.
Neurology Update 4: Multiple Sclerosis and Autoimmune Neurology
Vijay Ramanan, MD, PhD, reviewed “the current therapeutic landscape for relapsing multiple sclerosis (MS); [provided] an updated framework for MS progression and [discussed] the current state of therapeutic development in progressive MS; [reviewed] current data and therapeutic options in radiologically isolated syndrome; [and discussed] current MRI guidelines and new MRI techniques that may help avoid misdiagnosis of MS.
Continuum® Test Your Knowledge: A Multiple-choice Question Review 2
Ralph Jozefowicz, MD, FAAN, sought to “increase and refresh” participants’ “knowledge of the core topics of multiple sclerosis and movement disorders through presentation of common and not-so-common clinical problems,” also helping participants “learn to work through difficult clinical presentations both logically and successfully.”
Advances in Progressive MS
Ilana Katz Sand, MD, spoke about the latest developments of interest to clinicians that have occurred in progressive multiple sclerosis.
MS, Neuroimmunology, Neuroinfectious Disease, and Cultural Competency In Transgender and Gender Diverse Patients
Cole Harrington, MD, PhD, defined “terminology and concepts relevant to the care of transgender and gender diverse people, [described] current best practices in the neurologic care of transgender and gender diverse people, and [identified] interventions to promote an inclusive clinical practice and workplace.”
For more information check out AAN’s website.
